Minimizing false positives for CTC identification.

Anal Chim Acta

International Iberian Nanotechnology Laboratory, Avenida Mestre José Veiga s/n, 4715-330, Braga, Portugal; RUBYnanomed Lda, Praça Conde de Agrolongo 123, 4700-312, Braga, Portugal. Electronic address:

Published: February 2024

Background: Cancer is a leading cause of death worldwide, with metastasis playing a significant role. Circulating Tumour Cells (CTCs) can provide important real-time insights into tumour heterogeneity and clonal evolution, making them an important tool for early diagnosis and patient monitoring. Isolated CTCs are typically identified by immunocytochemistry using positive biomarkers (cytokeratin) and exclusion biomarkers (CD45). However, some white blood cell (WBC) populations can express low levels of CD45 and stain non-specifically for cytokeratin, increasing their risk of misclassification as CTCs. There is a clear need to improve CTC detection and enumeration criteria to unequivocally eliminate interfering WBC populations.

Results: This study showed that, indeed, some granulocyte subpopulations expressed low levels of CD45 and stained non-specifically for cytokeratin, misidentifying them as CTCs. These same cells, however, strongly expressed CD15, allowing them to be identified as WBCs and excluded from CTC classification. Flow cytometry confirmed the specificity of the CD15 antibody for the granulocyte subpopulation. False positives were considerably reduced from 25 % to 0.2 % by double exclusion, combining a CD15 antibody with a highly specific CD45 antibody. Furthermore, complete elimination of potential false positives was achieved using double exclusion in combination with improved selection of cytokeratin antibody. The study emphasises the importance of a robust exclusion criteria and high antibody specificity in CTC immuno-assays for accurate identification of CTC candidates and thorough exclusion of interfering WBC subpopulations.

Significance: This study demonstrated how misidentifying a granulocyte subpopulation can lead to inaccurate CTC evaluation. However, sensitivity and specificity of CTC identification may be improved by using high-performing antibodies and by including a second exclusion biomarker, in turn, allowing for a more comprehensive clinical application of CTCs.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.aca.2023.342165DOI Listing

Publication Analysis

Top Keywords

false positives
12
ctc identification
8
low levels
8
levels cd45
8
non-specifically cytokeratin
8
interfering wbc
8
cd15 antibody
8
granulocyte subpopulation
8
double exclusion
8
specificity ctc
8

Similar Publications

Objective: The objective of this study is to analyse the perspectives of screening candidates and healthcare professionals on shared decision-making (SDM) in prostate cancer (PCa) screening using the prostate-specific antigen (PSA) test.

Design: Descriptive qualitative study (May-December 2022): six face-to-face focus groups and four semistructured interviews were conducted, transcribed verbatim and thematically analysed using ATLAS.ti software.

View Article and Find Full Text PDF

Background: Multianalyte machine learning (ML) models can potentially identify previously undetectable wrong blood in tube (WBIT) errors, improving upon current single-analyte delta check methodology. However, WBIT detection model performance has not been assessed in a real-world, low-prevalence context. To estimate real-world positive predictive values, we propose a methodology to assess WBIT detection models by evaluating the impact of missing data and by using a "low prevalence" validation data set.

View Article and Find Full Text PDF

Artificial Intelligence in Sepsis Management: An Overview for Clinicians.

J Clin Med

January 2025

Anesthesiology, Critical Care and Pain Medicine Division, Department of Medicine and Surgery, University of Parma, Viale Gramsci 14, 43126 Parma, Italy.

Sepsis is one of the leading causes of mortality in hospital settings, and early diagnosis is a crucial challenge to improve clinical outcomes. Artificial intelligence (AI) is emerging as a valuable resource to address this challenge, with numerous investigations exploring its application to predict and diagnose sepsis early, as well as personalizing its treatment. Machine learning (ML) models are able to use clinical data collected from hospital Electronic Health Records or continuous monitoring to predict patients at risk of sepsis hours before the onset of symptoms.

View Article and Find Full Text PDF

The Loess Plateau in northwest China features fragmented terrain and is prone to landslides. However, the complex environment of the Loess Plateau, combined with the inherent limitations of convolutional neural networks (CNNs), often results in false positives and missed detection for deep learning models based on CNNs when identifying landslides from high-resolution remote sensing images. To deal with this challenge, our research introduced a CNN-transformer hybrid network.

View Article and Find Full Text PDF

Analysis of Autonomous Penetration Testing Through Reinforcement Learning and Recommender Systems.

Sensors (Basel)

January 2025

Group of Analysis, Security and Systems (GASS), Department of Software Engineering and Artificial Intelligence (DISIA), Faculty of Computer Science and Engineering, Office 431, Universidad Complutense de Madrid (UCM), Calle Profesor José García Santesmases, 9, Ciudad Universitaria, 28040 Madrid, Spain.

Conducting penetration testing (pentesting) in cybersecurity is a crucial turning point for identifying vulnerabilities within the framework of Information Technology (IT), where real malicious offensive behavior is simulated to identify potential weaknesses and strengthen preventive controls. Given the complexity of the tests, time constraints, and the specialized level of expertise required for pentesting, analysis and exploitation tools are commonly used. Although useful, these tools often introduce uncertainty in findings, resulting in high rates of false positives.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!